−£1.51m
vs Mar 2024From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Diome Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Diome Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DIOME LIMITED is an active private limited company (company number 13276149) incorporated on 18 March 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of −£1.51m, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 80% on the prior period (−£840k).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Ms Jianne Jamil
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 March 20215 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 1 April 2027in 158 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£1.51m | — | — | — | — | — | 1 |
| 31 March 2024 | −£840k | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,508,209 at 31 March 2025
- Net assets down 25% or more on the prior period-79.5% vs prior period
- Incorporated five or more years agoIncorporated 18 March 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 158 days
- Next accounts duein 67 days
- Accounts period endNet liabilities £1.51m · micro accounts
- Accounts period endNet liabilities £840k · micro accounts
- Incorporated
08
Similar companies in London
- POOLBEG PHARMA (UK) LIMITEDLondon · inc. Mar 2021
- POOLBEG PHARMA PLCLondon · inc. Mar 2021
- HCON ELEMENTS LIMITEDLondon · inc. Mar 2021
- BIOCORTEX LTDLondon · inc. Mar 2021
- INVOX PHARMA LIMITEDLondon · inc. Mar 2021
- MEDUSA PHARMACEUTICALS LTDLondon · inc. Mar 2021
All companies incorporated on 18 March 2021 · in Mar 2021.
09
Reminders for DIOME LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.